Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


12.11.2018

1 Ann Oncol
3 Ann Surg Oncol
7 Anticancer Res
5 BMC Cancer
3 Br J Cancer
1 Breast Cancer (Dove Med Press)
2 Breast Cancer Res
12 Breast Cancer Res Treat
1 Breast J
1 Cancer
3 Cancer Lett
2 Clin Breast Cancer
1 Eur J Cancer
6 Eur J Surg Oncol
1 Eur Radiol
1 Genes Chromosomes Cancer
2 Int J Cancer
1 J Biol Chem
1 J Natl Cancer Inst
3 J Surg Oncol
1 Lancet Oncol
1 NPJ Breast Cancer
1 PLoS Biol
3 PLoS One
2 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. FOUKAKIS T
    Carboplatin in the neoadjuvant treatment of triple-negative breast cancer - ready for prime time?
    Ann Oncol. 2018 Nov 5. pii: 5160131. doi: 10.1093.
    PubMed     Text format    


    Ann Surg Oncol

  2. WINTERS ZE, Benson JR
    Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-6982.
    PubMed     Text format    

  3. FAYANJU OM
    ASO Author Reflections: Metaplastic Breast Cancer-The Case for Doing Less and More.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-7009.
    PubMed     Text format    

  4. ELDER K, Nickson C, Mann GB
    ASO Author Reflections: Impact of Breast Cancer Screening Beyond Mortality Reductions.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-7001.
    PubMed     Text format    


    Anticancer Res

  5. MUSA MA, Badisa VLD, Latinwo LM, Ntantie E, et al
    7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells.
    Anticancer Res. 2018;38:6091-6098.
    PubMed     Text format     Abstract available

  6. TOROPOV AA, Toropova AP
    Predicting Cytotoxicity of 2-Phenylindole Derivatives Against Breast Cancer Cells Using Index of Ideality of Correlation.
    Anticancer Res. 2018;38:6189-6194.
    PubMed     Text format     Abstract available

  7. SHI H, Liu J, Tu Y, Freter CE, et al
    Oolong Tea Extract Induces DNA Damage and Cleavage and Inhibits Breast Cancer Cell Growth and Tumorigenesis.
    Anticancer Res. 2018;38:6217-6223.
    PubMed     Text format     Abstract available

  8. FU S, Lin J
    Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells.
    Anticancer Res. 2018;38:6271-6279.
    PubMed     Text format     Abstract available

  9. DU X, Klaschik K, Mallmann P, Isachenko E, et al
    An Experimental Model of Breast Cancer Cells: Informative Protocol for In Vitro Culture.
    Anticancer Res. 2018;38:6237-6245.
    PubMed     Text format     Abstract available

  10. SAKAGUCHI M, Maebayashi T, Aizawa T, Ishibashi N, et al
    Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis.
    Anticancer Res. 2018;38:6405-6411.
    PubMed     Text format     Abstract available

  11. STEFANOU D, Kokkali S, Tripodaki ES, Drizou M, et al
    Subcutaneous Trastuzumab Combined with Pertuzumab and Docetaxel as First-line Treatment of Advanced HER2-positive Breast Cancer.
    Anticancer Res. 2018;38:6565-6569.
    PubMed     Text format     Abstract available


    BMC Cancer

  12. AIDERUS A, Black MA, Dunbier AK
    Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
    BMC Cancer. 2018;18:805.
    PubMed     Text format     Abstract available

  13. RICHTER-EHRENSTEIN C, Maak K, Roger S, Ehrenstein T, et al
    Lesions of "uncertain malignant potential" in the breast (B3) identified with mammography screening.
    BMC Cancer. 2018;18:829.
    PubMed     Text format     Abstract available

  14. VAN BASTELAAR J, Granzier R, van Roozendaal LM, Beets G, et al
    A multi-center, double blind randomized controlled trial evaluating flap fixation after mastectomy using sutures or tissue glue versus conventional closure: protocol for the Seroma reduction After Mastectomy (SAM) trial.
    BMC Cancer. 2018;18:830.
    PubMed     Text format     Abstract available

  15. RINNERTHALER G, Gampenrieder SP, Petzer A, Burgstaller S, et al
    Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
    BMC Cancer. 2018;18:1074.
    PubMed     Text format     Abstract available

  16. OBERSTE M, Schaffrath N, Schmidt K, Bloch W, et al
    Protocol for the "Chemobrain in Motion - study" (CIM - study): a randomized placebo-controlled trial of the impact of a high-intensity interval endurance training on cancer related cognitive impairments in women with breast cancer receiving first-line
    BMC Cancer. 2018;18:1071.
    PubMed     Text format     Abstract available


    Br J Cancer

  17. MADSSEN TS, Thune I, Flote VG, Lundgren S, et al
    Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment.
    Br J Cancer. 2018;119:1144-1154.
    PubMed     Text format     Abstract available

  18. BECKWITT CH, Clark AM, Ma B, Whaley D, et al
    Statins attenuate outgrowth of breast cancer metastases.
    Br J Cancer. 2018;119:1094-1105.
    PubMed     Text format     Abstract available

  19. SNELL CE, Gough M, Liu C, Middleton K, et al
    Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-alpha and progesterone receptor-b.
    Br J Cancer. 2018 Nov 9. pii: 10.1038/s41416-018-0331.
    PubMed     Text format     Abstract available


    Breast Cancer (Dove Med Press)

  20. LOZANO C, Cordova C, Marchant I, Zuniga R, et al
    Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients.
    Breast Cancer (Dove Med Press). 2018;10:161-168.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  21. HOPPER JL, Dite GS, MacInnis RJ, Liao Y, et al
    Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC).
    Breast Cancer Res. 2018;20:132.
    PubMed     Text format     Abstract available

  22. SUCHANSKI J, Grzegrzolka J, Owczarek T, Pasikowski P, et al
    Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression.
    Breast Cancer Res. 2018;20:133.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  23. LI T, Yang J, Lv Y, Yin F, et al
    Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer.
    Breast Cancer Res Treat. 2018 Nov 2. pii: 10.1007/s10549-018-5029.
    PubMed     Text format     Abstract available

  24. DROGEMOLLER BI, Wright GEB, Shih J, Monzon JG, et al
    CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines.
    Breast Cancer Res Treat. 2018 Nov 8. pii: 10.1007/s10549-018-5027.
    PubMed     Text format     Abstract available

  25. BUSCARIOLLO DL, Cronin AM, Borstelmann NA, Punglia RS, et al
    Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women.
    Breast Cancer Res Treat. 2018 Nov 8. pii: 10.1007/s10549-018-5006.
    PubMed     Text format     Abstract available

  26. GUDINA AT, Copeland G, Soliman AS, Hirko KA, et al
    Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
    Breast Cancer Res Treat. 2018 Nov 7. pii: 10.1007/s10549-018-5037.
    PubMed     Text format     Abstract available

  27. SKULI SJ, Sheng JY, Bantug ET, Zafman N, et al
    Survivorship care visits in a high-risk population of breast cancer survivors.
    Breast Cancer Res Treat. 2018 Nov 7. pii: 10.1007/s10549-018-5028.
    PubMed     Text format     Abstract available

  28. XUE C, Wei W, Sun P, Zheng W, et al
    Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer.
    Breast Cancer Res Treat. 2018 Nov 3. pii: 10.1007/s10549-018-4997.
    PubMed     Text format     Abstract available

  29. HOPPE EJ, Hussain LR, Grannan KJ, Dunki-Jacobs EM, et al
    Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities.
    Breast Cancer Res Treat. 2018 Nov 3. pii: 10.1007/s10549-018-5036.
    PubMed     Text format     Abstract available

  30. COELHO BA, Paiva SPC, da Silva Filho AL
    Extremely brief mindfulness interventions for women undergoing breast biopsies: a randomized controlled trial.
    Breast Cancer Res Treat. 2018;171:685-692.
    PubMed     Text format     Abstract available

  31. PARK S, Moon BI, Oh SJ, Lee HB, et al
    Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society.
    Breast Cancer Res Treat. 2018 Nov 2. pii: 10.1007/s10549-018-5032.
    PubMed     Text format     Abstract available

  32. EULER-CHELPIN MV, Lillholm M, Napolitano G, Vejborg I, et al
    Screening mammography: benefit of double reading by breast density.
    Breast Cancer Res Treat. 2018;171:767-776.
    PubMed     Text format     Abstract available

  33. JANSEN LE, Teft WA, Rose RV, Lizotte DJ, et al
    CYP2D6 genotype and endoxifen plasma concentration do not predict hot flash severity during tamoxifen therapy.
    Breast Cancer Res Treat. 2018;171:701-708.
    PubMed     Text format     Abstract available

  34. LURASCHI R, Lazzari R, Galimberti V, Rondi E, et al
    Dosimetric study to assess the feasibility of intraoperative radiotherapy with electrons (ELIOT) as partial breast irradiation for patients with cardiac implantable electronic device (CIED).
    Breast Cancer Res Treat. 2018;171:693-699.
    PubMed     Text format     Abstract available


    Breast J

  35. ASAGA S, Kinoshita T, Shiino S, Jimbo K, et al
    Prognostic factors for breast cancer patients with T1-2 tumor and 1-3 positive axillary nodes treated using total mastectomy without radiotherapy.
    Breast J. 2018 Nov 9. doi: 10.1111/tbj.13148.
    PubMed     Text format     Abstract available


    Cancer

  36. TABAR L, Dean PB, Chen TH, Yen AM, et al
    The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
    Cancer. 2018 Nov 8. doi: 10.1002/cncr.31840.
    PubMed     Text format     Abstract available


    Cancer Lett

  37. SUN HF, Yang XL, Zhao Y, Tian Q, et al
    Loss of TMEM126A promotes extracellular matrix remodeling, epithelial-to-mesenchymal transition, and breast cancer metastasis by regulating mitochondrial retrograde signaling.
    Cancer Lett. 2018;440-441:189-201.
    PubMed     Text format     Abstract available

  38. GUPTA P, Gupta N, Fofaria NM, Ranjan A, et al
    HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells.
    Cancer Lett. 2018;442:68-81.
    PubMed     Text format     Abstract available

  39. WEN S, Hou Y, Fu L, Xi L, et al
    Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin beta3-p38 MAPK signalling.
    Cancer Lett. 2018 Oct 26. pii: S0304-3835(18)30629.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  40. PANDEY A, Brufsky AM
    Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib: Case Report of Compassionate Drug Use.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30317.
    PubMed     Text format    

  41. DING S, Wu J, Lin C, Chen W, et al
    Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2018 Oct 13. pii: S1526-8209(18)30393.
    PubMed     Text format     Abstract available


    Eur J Cancer

  42. ZAMBETTI M, Montemurro F, Morandi P, Zamagni C, et al
    Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY study.
    Eur J Cancer. 2018;105:61-70.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  43. AHMEIDAT H, Purdie C, Jordan L, Fleming D, et al
    Non-histopathological parameters associated with upgrade of breast tumours yielding a core biopsy report of histological grade 2 ductal no special type to grade 3 on excision.
    Eur J Surg Oncol. 2018;44:1720-1724.
    PubMed     Text format     Abstract available

  44. YU TJ, Liu YY, Hu X, Di GH, et al
    Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Eur J Surg Oncol. 2018;44:1703-1707.
    PubMed     Text format     Abstract available

  45. LIM GH, Lee J, Yen CC
    Virtual breast oncoplastic surgery simulator (VBOSS): A novel training tool in breast surgery.
    Eur J Surg Oncol. 2018;44:1750-1753.
    PubMed     Text format     Abstract available

  46. FLANAGAN M, Solon J, Chang KH, Deady S, et al
    Peritoneal metastases from extra-abdominal cancer - A population-based study.
    Eur J Surg Oncol. 2018;44:1811-1817.
    PubMed     Text format     Abstract available

  47. HERSI AF, Eriksson S, Ramos J, Abdsaleh S, et al
    A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
    Eur J Surg Oncol. 2018 Oct 23. pii: S0748-7983(18)31467.
    PubMed     Text format     Abstract available

  48. ADAM MJ, Bendifallah S, Kalhorpour N, Cohen-Steiner C, et al
    Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study.
    Eur J Surg Oncol. 2018;44:1743-1749.
    PubMed     Text format     Abstract available


    Eur Radiol

  49. XIE T, Zhao Q, Fu C, Bai Q, et al
    Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
    Eur Radiol. 2018 Nov 6. pii: 10.1007/s00330-018-5804.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  50. DICKSON BC, Hornick JL, Fletcher CDM, Demicco EG, et al
    Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast.
    Genes Chromosomes Cancer. 2018;57:437-445.
    PubMed     Text format     Abstract available


    Int J Cancer

  51. MINICOZZI P, Van Eycken L, Molinie F, Innos K, et al
    Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer.
    Int J Cancer. 2018 Nov 8. doi: 10.1002/ijc.31974.
    PubMed     Text format     Abstract available

  52. ASLEH K, Lyck Carstensen S, Tykjaer Jorgensen CL, Burugu S, et al
    Basal biomarkers Nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: samples from the phase III SBG0102 clinical trial.
    Int J Cancer. 2018 Nov 9. doi: 10.1002/ijc.31969.
    PubMed     Text format     Abstract available


    J Biol Chem

  53. SUBBARAMAIAH K, Iyengar NM, Morrow M, Elemento O, et al
    Prostaglandin E2down-regulates sirtuin 1 (SIRT1) leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection.
    J Biol Chem. 2018 Nov 8. pii: RA118.005866. doi: 10.1074/jbc.RA118.005866.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  54. CARREIRA H, Williams R, Muller M, Harewood R, et al
    Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review.
    J Natl Cancer Inst. 2018 Nov 7. pii: 5164282. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  55. JIN L, Wu X, Zha L, Feng Y, et al
    Adjacent skin rotation flap for large defect in primary breast tumor.
    J Surg Oncol. 2018;118:1199-1204.
    PubMed     Text format     Abstract available

  56. LAWS A, Brar MS, Bouchard-Fortier A, Leong B, et al
    Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
    J Surg Oncol. 2018;118:1205-1211.
    PubMed     Text format     Abstract available

  57. JOHNSON AR, Singhal D
    Immediate lymphatic reconstruction.
    J Surg Oncol. 2018;118:750-757.
    PubMed     Text format     Abstract available


    Lancet Oncol

  58. VAN RAMSHORST MS, van der Voort A, van Werkhoven ED, Mandjes IA, et al
    Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
    Lancet Oncol. 2018 Nov 6. pii: S1470-2045(18)30570.
    PubMed     Text format     Abstract available


    NPJ Breast Cancer

  59. YANG B, Chou J, Tao Y, Wu D, et al
    An assessment of prognostic immunity markers in breast cancer.
    NPJ Breast Cancer. 2018;4:35.
    PubMed     Text format     Abstract available


    PLoS Biol

  60. TAN P, Ye Y, He L, Xie J, et al
    TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
    PLoS Biol. 2018;16:e3000051.
    PubMed     Text format     Abstract available


    PLoS One

  61. BEZERRA IC, da Silva RM, Oliveira CP, Brasil CCP, et al
    Mastectomized women's perception of breast cancer early detection.
    PLoS One. 2018;13:e0206405.
    PubMed     Text format     Abstract available

  62. SALAGAME U, Banks E, O'Connell DL, Egger S, et al
    Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
    PLoS One. 2018;13:e0205034.
    PubMed     Text format     Abstract available

  63. VENUGOPAL V, Krishnan S, Palanimuthu VR, Sankarankutty S, et al
    Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
    PLoS One. 2018;13:e0206109.
    PubMed     Text format     Abstract available


    Radiother Oncol

  64. LUO L, Cuaron J, Braunstein L, Gillespie E, et al
    Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy.
    Radiother Oncol. 2018 Nov 7. pii: S0167-8140(18)33507.
    PubMed     Text format     Abstract available

  65. TRIVEDI SJ, Choudhary P, Lo Q, Sritharan HP, et al
    Persistent reduction in global longitudinal strain in the longer term after radiation therapy in patients with breast cancer.
    Radiother Oncol. 2018 Nov 7. pii: S0167-8140(18)33547.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: